Boston Scientific Announces Results For First Quarter 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Boston Scientific (BSX) PT Raised to $30 at Needham & Company
April 27, 2017 3:58 PM EDTNeedham & Company raised its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $29.00) while maintaining a Buy rating.
... MoreBoston Scientific (BSX) PT Raised to $30 at Stifel
April 27, 2017 3:55 PM EDTStifel raised its price target on Boston Scientific (NYSE: BSX) to $30.00 (from $28.00) while maintaining a Buy rating.
... MoreBoston Scientific (BSX) PT Raised to $31 at Cowen
April 27, 2017 1:03 PM EDTCowen raised its price target on Boston Scientific (NYSE: BSX) to $31.00 (from $29.00) while maintaining a Outperform rating amid "robust" top-line performance.
Analyst Joshua Jennings said the reason the company gave for the margin shortfall - non-recurring expenses- is "very plausible" and they... More
Boston Scientific (BSX) PT Raised to $28.50 at Evercore ISI; Revenue Beat was 'Remarkable'
April 27, 2017 12:00 PM EDTEvercore ISI raised its price target on Boston Scientific (NYSE: BSX) to $28.50 (from $26.50) while maintaining a Outperform rating after the company "curshed" it on revenues for the quarter.
Analyst Vijay Kumar, "In large cap land, organic revenue beats of >400 bps... More

